Marilyn Miller, Ph.D. began as Program Director for the Genetics of Alzheimer's Disease, Tau, and Hormone Research portfolios at the National Institute on Aging (NIA) in 2000. A major component of her portfolio is the Alzheimer’s Disease Sequencing Project (ADSP), an initiative that moves the field closer to achieving National Alzheimer’s Project Act goal. The Project emphasizes generation and analysis of sequence data from large AD cohorts including several diversity sample sets and a large family based study. The Project includes two major AD genetics consortia, the NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS); a Genomics Center, and several cooperative agreements that fund the Discovery and Replication Phases of the Project. Dr. Miller is involved in all aspects of the ADSP, including monitoring and assessing progress, coordinating numerous projects, and implementing policies related to data deposition and release of human sequence data, and strategic planning. Before joining NIH, she held joint faculty appointments in the Departments of Obstetrics and Gynecology, Experimental Medicine, and Anatomy at McGill University, Montreal, Canada. Her research interests have included: reproductive biology, reproductive aging and hormone regulation; age-related changes and gene regulation in neurotransmitter systems; and neuropeptide biosynthesis and processing, neuropharmacology, and neurodegeneration. She received a bachelor’s degree from Marquette University, Milwaukee; a master’s degree in Biology at Loyola University of Chicago; and a Ph.D. in Anatomy from Loyola University of Chicago, Stritch School of Medicine. She did a postdoctoral fellowship in reproductive biology at Case Western University and a sabbatical in endocrine-related molecular biology at the University of Colorado. Dr. Miller has published numerous peer-reviewed manuscripts, reviews, and book chapters and has served on a number of NIA and NIH-wide committees and work groups and served as the first chair of the NIH Program Leadership committee.
- genetics of Alzheimer's disease
- reproductive aging and hormone regulation
- age-related changes and gene regulation in neurotransmitter systems
- neuropeptide biosynthesis and processing